Close Menu
    Africa IndependentAfrica Independent
    • Automotive
    • Business
    • Entertainment
    • Health
    • Luxury
    • Lifestyle
    • News
    • Sports
    • Technology
    • Travel
    Africa IndependentAfrica Independent
    Home » Breakthrough in cell regeneration offers new hope for diabetes
    Health

    Breakthrough in cell regeneration offers new hope for diabetes

    January 10, 2024
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    In a groundbreaking development, researchers have discovered a method to regenerate insulin-producing cells in the pancreas, potentially revolutionizing diabetes treatment. This breakthrough, spearheaded by the Baker Heart and Diabetes Institute in Australia, involves repurposing FDA-approved drugs to stimulate the growth of pancreatic ductal progenitor cells, which can mimic the function of β-cells typically impaired in type 1 diabetes.

    Breakthrough in cell regeneration offers new hope for diabetes

    The study centers on two drugs, GSK126 and Tazemetostat, originally approved for cancer treatments. These drugs target the EZH2 enzyme, a key regulator of cell development, and by inhibiting this enzyme, the researchers were able to reprogram pancreatic ductal cells to produce and secrete insulin in response to glucose levels, akin to β-cells. This discovery is particularly significant for type 1 diabetes, where the immune system erroneously destroys β-cells, necessitating regular insulin injections to manage blood glucose levels.

    The research revealed that it only took 48 hours of drug-induced stimulation for regular insulin production to resume in tissue samples from individuals with and without diabetes, spanning various ages. Given the global prevalence of diabetes, affecting approximately 422 million people, this innovative approach offers a potential alternative to the constant monitoring and management of blood sugar levels. However, the research is still in its early stages, with clinical trials yet to commence.

    This advancement is not isolated; it forms part of a broader spectrum of scientific explorations into diabetes treatment, including new drug developments and strategies to protect insulin-producing cells before their destruction. Epigeneticist Sam El-Osta, from the Baker Heart and Diabetes Institute, highlights the importance of this regenerative approach for future clinical applications, emphasizing the need to understand the epigenetic mechanisms driving such regeneration in humans. The full details of this research have been published in Signal Transduction and Targeted Therapy.

    Related Posts

    Congo Ebola death toll reaches 5,568 as cases pass 11,000

    November 18, 2026

    Africa CDC says Congo Ebola outbreak still not under control

    November 16, 2026

    WHO reports 67 yellow fever cases in nine African countries

    November 7, 2026

    Bangladesh dengue deaths reach 418 after deadliest month of 2026

    November 2, 2026

    DR Congo Ebola death toll climbs to 5,340 as cases reach 10,351

    November 2, 2026

    DR Congo Ebola cases top 10,000 in fastest-growing outbreak

    October 28, 2026
    Latest News

    Botswana opens consultations on proposed 33 percent hike now

    November 19, 2026

    PM Modi meets Prince and Princess of Wales in New Delhi

    November 19, 2026

    Congo Ebola death toll reaches 5,568 as cases pass 11,000

    November 18, 2026

    DXB handles 50.4 million passengers in first nine months

    November 18, 2026

    Rand slips toward R17 as inflation and weak growth cloud outlook

    November 18, 2026

    Tunisia tourism revenues top $2.38 billion by end-October

    November 17, 2026

    UAE President and Venezuela’s acting leader discuss closer ties

    November 17, 2026

    Africa CDC says Congo Ebola outbreak still not under control

    November 16, 2026

    UAE and Timor-Leste presidents discuss stronger bilateral ties

    November 16, 2026
    © 2026 Africa Independent | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.